pipette
ENEnglish

BRO is a proteinaceous binding receptor for human coronavirus OC43

J. Song, Y.-J. Park, M. A. Tortorici, L. Zhang, S. Moon, A. Addetia, V. V. Poosapati, C. A. Tsu, J. T. Brown, C. Stewart, S. R. Ling, B. Merz, A. Aka, Z. Zhao, E. F. Foxman, A. Jamieson, C. B. Wilen, D. Veesler, S. Lee

PreprintUso en el mundo real

En palabras de los autores

Embecoviruses such as human coronavirus (HCoV) OC43 have long been viewed as sialic acid-dependent viruses that attach to cells through interactions with cell surface sialoglycans. Here, we identify a specific proteinaceous receptor that harbors the sialoglycan determinant and also contributes protein contacts for viral spike (S) recognition. Using an unbiased surfaceome CRISPR activation screen for OC43 spike binding, we discovered that the previously uncharacterized human gene C1ORF54 encodes this receptor, which we name Binding Receptor for OC43 (BRO). BRO engages the OC43 S N-terminal domain through O-linked 9-O-acetylated sialoside determinants and neighboring protein contacts. BRO expression in human cells promotes OC43 infection, whereas BRO knockout or blockade with the BRO ectodomain or anti-BRO antibody inhibit infection, including in differentiated primary human airway cultures. BRO orthologs from diverse mammals support OC43 infection when expressed in human cells, suggesting potential contributions to OC43 zoonotic circulation and cross-species transmission. Our findings reshape our understanding of OC43 entry, and pave the way to develop countermeasures targeting this receptor interaction.

Resultado principalEl resumen no menciona limitaciones.

Apareció: jueves, 19 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.11.18.767413